JP Patent

JP2018012715A — 核内輸送調節因子およびその使用

Assigned to Karyopharm Therapeutics Inc · Expires 2018-01-25 · 8y expired

What this patent protects

【課題】核輸送を調節する化合物を提供する。【解決手段】式Ｉの化合物又はその薬学的に許容可能な塩。【選択図】なし

USPTO Abstract

【課題】核輸送を調節する化合物を提供する。【解決手段】式Ｉの化合物又はその薬学的に許容可能な塩。【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number: JP2018012715A
Jurisdiction: JP
Classification: —
Expires: 2018-01-25
Drug substance claim: No
Drug product claim: No
Assignee: Karyopharm Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.